ADVERTISEMENT

Dr Lal PathLabs CEO Explains Business Model Ahead of IPO

Dr. Manchanda believes that its internal accruals of Rs 235 crore are sufficient to support future expansion.
Dr. Manchanda believes that its internal accruals of Rs 235 crore are sufficient to support future expansion.
Dr Lal PathLabs will hit capital markets with its initial public offer (IPO) on December 8, 2015. The diagnostic company is offering 1.16 crore equity shares, which is 14 per cent stake in the company. The price band for the offer is Rs 540- Rs 550. At the upper end of the price band, the company may garner Rs 632 crores. The IPO is primarily an offer for sale as the company is not raising any fresh capital through this issue. The p...
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit